Menu Back toThe Future of Clinical Trial Transparency – 3 Trends for 2021

The Future of Clinical Trial Transparency – 3 Trends for 2021


Overview

Brought to you by DIA in cooperation with

Kernel


In this session, we’ll discuss three emergent trends destined to have a major impact on your transparency planning for 2021. The race to create effective drug responses to COVID-19 has driven new levels of collaboration and is forcing clinical trial sponsors to think prospectively about the different contexts in which their trial data may be re-used to improve health outcomes. At the same time, clinical document sharing regulations continue to evolve. Your transparency teams need to meet these challenges head-on if your organization wants to remain viable.

Featured topics

  • The shift in clinical trial transparency regulations and expectations
  • Robust data-sharing strategies to enhance brand reputation and foster internal innovation
  • The role of statistical anonymization in producing useful data and documents for secondary use

Learning objectives

Upon completion of the webinar, participants will have a better understanding of:

  • Understand what the transition from competitive (data-sheltering) to collaborative (data-sharing) means for your organization
  • Learn how a global drug developer ensured success with its safe & responsible COVID-19 data sharing
  • Discover how statistical anonymization balances data utility and patient privacy

Continuing Education Credits are not available for this event.


Contact us

Registration or Event Questions?

Send Email

Zoom Technical Support

Send Email


Want more Virtual Events?

View live and on demand solution provider webinars